Clinical Trials Logo
  1. Home
  2. Schizophrenia
  3. NCT00692133
  4. Details
NCT00692133 Clinical Trial

Spanish Validation of Tool Questionnaire to Assess Patients´Perception About Antipsychotic Treatment

Schizophrenia Clinical Trial

— TOOL  

Official title:
Spanish Validation of Tool Questionnaire to Assess Patients´Perception About Antipsychotic Treatment

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT00692133
Other study ID # NIS-NES-DUM-2007/2
Secondary ID
Status Completed
Phase N/A
First received June 5, 2008
Last updated December 8, 2010
Start date March 2008
Est. completion date August 2008

Study information
Verified date December 2010
Source AstraZeneca
Contact n/a
Is FDA regulated No
Health authority Spain: Ethics Committee
Study type Observational

Clinical Trial Summary

Non-interventional, prospective study to validate Spanish version of TOOL questionnaire in patients with schizophrenia and bipolar disorder under antipsychotic treatment

Recruitment information / eligibility
Status Completed
Enrollment 250
Est. completion date August 2008
Est. primary completion date August 2008
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Schizophrenia and bipolar disorder (DSM-IV criteria)

- Stabilized out-patients

- Treated with the same oral antipsychotic at least in the last month

Exclusion Criteria:

- Participation in another clinical trial within 6 months prior to enrolment into this study

- Administration of a depot antipsychotic medication

Study Design

Time Perspective: Prospective

Related Conditions & MeSH terms

Locations
Country Name City State
Spain Research Site Alcobendas Madrid
Spain Research Site Alzira Valencia
Spain Research Site Atarfe Granada
Spain Research Site Burgos
Spain Research Site Castellon
Spain Research Site Ceuta
Spain Research Site Coruna
Spain Research Site Elizondo Navarra
Spain Research Site Estepona Malaga
Spain Research Site Galdako Vizcaya
Spain Research Site Gava Barcelona
Spain Research Site Granada
Spain Research Site Leon
Spain Research Site Linares Jaen
Spain Research Site Madrid
Spain Research Site Malaga
Spain Research Site Mondragon Guipuzcoa
Spain Research Site Murcia
Spain Research Site Oviedo Asturias
Spain Research Site Palma Baleares
Spain Research Site Pamplona Navarra
Spain Research Site Parla Madrid
Spain Research Site Pontevedra
Spain Research Site Puerto Real Cadiz
Spain Research Site Sagunto Valencia
Spain Research Site Salamanca
Spain Research Site San Sebastian Guipuzcoa
Spain Research Site Santander Cantabria
Spain Research Site Tarragona
Spain Research Site Tudela Navarra
Spain Research Site Vitoria Alava
Spain Research Site Zamudio Vizcaya

Sponsors (1)
Lead Sponsor Collaborator
AstraZeneca

Country where clinical trial is conducted

Spain, 

Outcome
Type Measure Description Time frame Safety issue
Primary TOOL questionnaire 15 days
Primary PANSS & Young Mania Scale 15 days
Secondary Montgomery Asberg Depression Scale 15 days
Secondary Euroqol 5D & SF-36D performed only at baseline visit
Secondary UKU modified scale performed only at baseline visit
See also
  Status Clinical Trial Phase
Recruiting NCT05039489 - A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia N/A
Completed NCT05321602 - Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder Phase 1
Completed NCT05111548 - Brain Stimulation and Cognitive Training - Efficacy N/A
Completed NCT04503954 - Efficacy of Chronic Disease Self-management Program in People With Schizophrenia N/A
Completed NCT02831231 - Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium Phase 1
Completed NCT05517460 - The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center N/A
Completed NCT03652974 - Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy Phase 4
Recruiting NCT04012684 - rTMS on Mismatch Negativity of Schizophrenia N/A
Recruiting NCT04481217 - Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia N/A
Completed NCT00212784 - Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935) Phase 3
Completed NCT04092686 - A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia Phase 3
Completed NCT01914393 - Pediatric Open-Label Extension Study Phase 3
Recruiting NCT03790345 - Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics Phase 2/Phase 3
Recruiting NCT05956327 - Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training N/A
Terminated NCT03209778 - Involuntary Memories Investigation in Schizophrenia N/A
Terminated NCT03261817 - A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders N/A
Completed NCT02905604 - Magnetic Stimulation of the Brain in Schizophrenia or Depression N/A
Recruiting NCT05542212 - Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia N/A
Completed NCT04411979 - Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia N/A
Terminated NCT03220438 - TMS Enhancement of Visual Plasticity in Schizophrenia N/A